RAMM Pharma Cancels Planned Private Placement

Ramm Pharma Corp (TSE:RAMM) has released an update.

RAMM Pharma Corp., a leader in cannabinoid pharmacology, has cancelled its previously announced private placement after withdrawing its appeal against the Canadian Securities Exchange’s decision which required shareholder approval. The company, with international production and sales in pharmaceuticals and hemp-based products, will communicate future financing plans at a later date. This strategic shift comes despite RAMM’s robust product pipeline and established market presence in Latin America and Europe.

For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.